Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Besser, Daniel Dr. (1) Blankenstein, Thomas Prof. Dr. (21) Chen, Wei Prof. Dr. (3) Daniel, Peter Prof. Dr. (1) Escobar Fernandez, Helena Dr. (1) Fröhlich, Janine (1) Hübner, Norbert Prof. Dr. (2) Ivics, Zoltan Dr. (35) Izsvak, Zsuzsanna Dr. (35) Kammertöns, Thomas Dr. (4) Kieback, Elisa Dr. (2) Kopp, Joachim Dr. (2) Marg, Andreas Dr. (1) Prigione, Alessandro Prof. Dr. (1) Saar, Kathrin Dr. (1) Schlag, Peter M. Prof. Dr. (1) Singh, Manvendra Dr. (3) Spuler, Simone Prof. (1) Willimsky, Gerald Dr. (7) (-) Bunse, Mario Dr. (2) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Pezzutto, Antonio Prof. Dr. (2) (-) Uckert, Wolfgang Prof. Dr. (8) Bioinformatik der Genregulation (1) Entwicklung Mechanismus-basierter Krebstherapien (1) Experimentelle Ultrahochfeld-MR (7) Genetik metabolischer und reproduktiver Störungen (3) Genom-Editierung & Krankheitsmodelle (2) Genomics (1) Hochschulambulanz für Neuroimmunologie (1) Immunregulation und Krebs (3) Magnetic Resonance (7) (-) Mobile DNA (2) (-) Molekulare Immunologie und Gentherapie (8) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (2) Zelluläre Neurowissenschaften (5) 1997 (2) 1998 (2) 1999 (1) 2000 (2) 2003 (4) 2004 (2) 2005 (5) 2006 (1) 2007 (3) (-) 2008 (1) (-) 2010 (2) (-) 2011 (3) 2013 (1) 2014 (1) 2015 (3) (-) 2016 (4) 2017 (2) 2018 (3) 2019 (1) 2020 (2) 2021 (1) 2022 (3) 10 Ergebnisse: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Prof. Dr. rer. nat.Pezzutto, Antonio Prof. Dr.Uckert, Wolfgang Prof. Dr.Mobile DNAMolekulare Immunologie und Gentherapie 2008201020112016 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. März 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau 01. März 2016 / Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 03. November 2016 / Blood In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors M. Richter K. Saydaminova R. Yumul R. Krishnan J. Liu E.E. Nagy M. Singh Z. Izsvák R. Cattaneo W. Uckert D. Palmer P. Ng K.G. Haworth H.P. Kiem A. Ehrhardt T. Papayannopoulou A. Lieber
01. März 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
01. März 2016 / Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
03. November 2016 / Blood In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors M. Richter K. Saydaminova R. Yumul R. Krishnan J. Liu E.E. Nagy M. Singh Z. Izsvák R. Cattaneo W. Uckert D. Palmer P. Ng K.G. Haworth H.P. Kiem A. Ehrhardt T. Papayannopoulou A. Lieber